These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20309789)

  • 21. Cerebral edema causing death in children with maple syrup urine disease.
    Riviello JJ; Rezvani I; DiGeorge AM; Foley CM
    J Pediatr; 1991 Jul; 119(1 Pt 1):42-5. PubMed ID: 2066857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic modeling of plasma leucine levels during continuous venovenous extracorporeal removal therapy in neonates with maple syrup urine disease.
    Jouvet P; Hubert P; Saudubray JM; Rabier D; Man NK
    Pediatr Res; 2005 Aug; 58(2):278-82. PubMed ID: 16085796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cranial computed tomography in a patient with a variant form of maple syrup urine disease.
    Suzuki S; Naito H; Abe T; Nihei K
    Neuropediatrics; 1983 May; 14(2):102-3. PubMed ID: 6877525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-volume continuous venovenous hemofiltration as an effective therapy for acute management of inborn errors of metabolism in young children.
    Lai YC; Huang HP; Tsai IJ; Tsau YK
    Blood Purif; 2007; 25(4):303-8. PubMed ID: 17643056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN; Francis DE; Halliday D
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms.
    Puckett RL; Lorey F; Rinaldo P; Lipson MH; Matern D; Sowa ME; Levine S; Chang R; Wang RY; Abdenur JE
    Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of branched-chain amino acids in blood spots and plasma by liquid chromatography tandem mass spectrometry for the diagnosis of maple syrup urine disease.
    Sowell J; Pollard L; Wood T
    J Sep Sci; 2011 Mar; 34(6):631-9. PubMed ID: 21328532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Maple syrup urine disease and cystathioninemia].
    Simma B; Sperl W; Berger H
    Padiatr Padol; 1989; 24(1):69-75. PubMed ID: 2497426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maple syrup urine disease-treatment and outcome in patients of Turkish descent in Germany.
    Simon E; Wendel U; Schadewaldt P
    Turk J Pediatr; 2005; 47(1):8-13. PubMed ID: 15884622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL; Huang SC; Hung FC; Wang HS; Sun PC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease.
    Snyderman SE; Goldstein F; Sansaricq C; Norton PM
    Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy].
    Qu SQ; Yang LC; Luan Z; Du K; Yang H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):161-4. PubMed ID: 22433398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maple syrup urine disease in Thai infants.
    Pangkanon S; Charoensiriwatana W; Sangtawesin V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Onset of hereditary metabolic encephalopathy can be seen after the neonatal period].
    Sørensen LC; Rehman S; Lund AM
    Ugeskr Laeger; 2016 May; 178(22):. PubMed ID: 27238151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microangiopathic hemolytic anemia, thrombocytopenia, and renal injury during continuous venovenous hemodialysis in a neonate.
    Sherbotie JR
    Pediatr Nephrol; 1995 Dec; 9(6):789-90. PubMed ID: 8747129
    [No Abstract]   [Full Text] [Related]  

  • 39. Branched-chain amino acid-free parenteral nutrition in the treatment of acute metabolic decompensation in patients with maple syrup urine disease.
    Berry GT; Heidenreich R; Kaplan P; Levine F; Mazur A; Palmieri MJ; Yudkoff M; Segal S
    N Engl J Med; 1991 Jan; 324(3):175-9. PubMed ID: 1898534
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
    Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
    J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.